AgeX Therapeutics ROE Ratio 2011-2026 | AGE

Annual ROE Ratio AgeX Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-270.67	60.78	73.32	-37.06	-464.42	-91.14	-	66.15	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
73.32	-464.42	-94.72

Quarterly ROE Ratio AgeX Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-911.48	-661.17	-335.09	10.95	5.7	10.64	40.09	-12.13	3.94	25.27	47.3	59.16	78.75	82.27	92.36	83.87	133.57	163.69	94.76	72.91	-72.31	-267.24	-367.42	-425.74	-454.63	-338.29	-224.94	-57.96	-57.96	-29.07	-3.16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
163.69	-911.48	-103.66

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	156.54	-	2.71 %	$ 14 M	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Black Diamond Therapeutics BDTX	-83.66	$ 2.38	-3.64 %	$ 131 M	USA
ARCA biopharma ABIO	-21.9	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-14.36	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
AIkido Pharma AIKI	-36.89	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	-19.38	-	-0.23 %	$ 916 M	USA
Alector ALEC	-466.34	$ 2.1	-13.79 %	$ 216 M	USA
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	-115.61	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	-51.87	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	-32.19	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	-256.9	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	559.76	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Athira Pharma ATHA	-216.19	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	125.33	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	-76.97	$ 4.2	-2.67 %	$ 298 M	USA
Arena Pharmaceuticals ARNA	-91.56	-	-6.81 %	$ 3.04 B	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Avenue Therapeutics ATXI	-418.16	-	-52.27 %	$ 4.45 M	USA
Athersys ATHX	-531.22	-	3.77 %	$ 22.4 M	USA
Axcella Health AXLA	-1949.71	-	-16.42 %	$ 249 M	USA
AstraZeneca PLC AZN	20.44	-	-	$ 96.9 B	Britain
AVEO Pharmaceuticals AVEO	-116.29	-	-	$ 521 M	USA
Atreca BCEL	-123.92	-	-11.76 %	$ 5.79 M	USA
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
Apellis Pharmaceuticals APLS	6.05	$ 20.61	-1.67 %	$ 2.6 B	USA
Agenus AGEN	160.57	$ 3.33	-	$ 1.19 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	-34.6	$ 28.87	-4.5 %	$ 1.67 B	USA
bluebird bio BLUE	-108.93	-	-	$ 546 M	USA
Brickell Biotech BBI	-57.34	-	-5.38 %	$ 6.06 M	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA